companydata.dkcompanydata.dk

LABEX ApS: Financial statements 2026

CVR: 19947394

Source: annual report 2026, Danish Business Authority

01/05/202530/04/2026

LABEX ApS (CVR 19947394) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 1,909,444 and a net result of DKK 991,782 compared with DKK 5,318 the year before. That is an increase of 117.4% compared with the year before. Equity in the 2026 report amounted to DKK 1,789,042. The solvency ratio was 69.1%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,909,444
Profit/Loss
DKK 991,782
Equity
DKK 1,789,042
Total Assets
DKK 2,587,260
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2026-1.9 mio.992 t.1.8 mio.1
2025-878 t.5 t.797 t.1
2024-1.5 mio.18 t.792 t.1
2023-2.5 mio.74 t.774 t.3
2022-2.4 mio.-155 t.700 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like LABEX ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2026

LABEX ApS wins public contractMar 6, 2026

LABEX ApS has won the tender "Blodbestråler til AUH, Blodbank og Immunologi" issued by Region Midtjylland worth 4,300,000 DKK.

About LABEX ApS

LABEX ApS is a Danish company of the type Anpartsselskab based in Valby, founded in 1996. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Max Pihlqvist. The company is owned by Svenska Labex AB. The company has 1 employee (2018). In 2026, the company reported a gross profit of DKK 1,909,444 and a net result of DKK 991,782 compared with DKK 5,318 the year before. Equity in the 2026 report amounted to DKK 1,789,042.

Source: annual report 2026, Danish Business Authority